Prevention of Olanzapine-induced Toxicities of Weight Gain and Inflammatory Reactions by Coadministration with Green Tea or its Major Component Phenolic Epigallocatechin 3-Gallate in Mouse |
Kim, Chul-Eung
(Department of Psychiatry, Medicinal Toxicology Research Center, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 project)
Mo, Ji-Won (Department of Pharmacology, Medicinal Toxicology Research Center, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 project) Kim, Jin (Department of Pharmacology, Medicinal Toxicology Research Center, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 project) Kang, Ju-Hee (Department of Pharmacology, Medicinal Toxicology Research Center, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 project) Park, Chang-Shin (Department of Pharmacology, Medicinal Toxicology Research Center, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 project) |
1 | Bell, S. J. & Goodrick, G. K. A functional food product for the management of weight. Crit. Rev. Food. Sci. Nutr. 42:163-178 (2002) DOI ScienceOn |
2 | Blum, W. F. Leptin: the voice of the adipose tissue. Horm. Res. 48:2-8 (1997) |
3 | Dulloo, A. G. et al. Efficacy of GT extract rich in catethin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr. 70:1040-1045 (1999) DOI |
4 | Eder, U. et al. Association of olanzapine-induced weight gain with an increase in body fat. Am. J. Psychiatry 158:1719-1722 (2001) DOI ScienceOn |
5 | Verdon, C. P., Burton, B. A. & Prior, R. L. Sample pretreatment with nitrate reductase and glucose-6- phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal. Biochem. 224:502-508 (1995) DOI ScienceOn |
6 | Ghaeli, P. & Dufresne, R. L. Elevated serum triglycerides on clozapine resolve with risperidone. Pharmacotherapy 1:382-385 (1995) |
7 | Choi, J. W. et al. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin. Chem. 47:1106-1109 (2001) |
8 | Gaudiot, N. et al. Modulation of white adipose tissue lipolysis by nitric oxide. J. Biol. Chem. 273:13475- 13481 (1998) DOI ScienceOn |
9 | Jung, W. W. et al. Development of proteomics and applications of proteomics in toxicology. Mol. Cell. Toxicol. 1:7-12 (2005) |
10 | Uchida, Y. et al. Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes. Eur. J. Pharmacol. 335:235-243 (1997) DOI ScienceOn |
11 | Osser, D. O., Najarian, D. M. & Dufresne, R. L. Olanzapine increases weight and serum triglycerides. J. Clin. Psychiatry 60:767-770 (1999) DOI |
12 | Dulloo, A.G. et al. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int. J. Obes. Relat. Metab. Disord. 24:252-258 (2000) DOI ScienceOn |
13 | Jang, E. H. et al. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats. J. Pharm. Pharmacol. 57:311-316 (2005) DOI ScienceOn |
14 | Green, A. I. et al. Weight gain from novel antipsychotic drugs: Need for action. Gen. Hosp. Psychiatry 22:224-235 (2000) DOI ScienceOn |
15 | Dulloo, A. G. & Miller, D. S. The thermogenic properties of ephedrine/methylxanthine mixtures: human studies. Int. J. Obes. 10:467-481 (1986) |
16 | Kao, Y. H., Hiipakka, R. A. & Liao, S. Modulation of obesity by a green tea catechin. Am. J. Clin. Nutr. 72:1232-1233 (2000a) DOI |
17 | Green, L. C. et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138 (1982) DOI ScienceOn |
18 | Wirshing, D. A. et al. Novel antipsychotics: comparison of weight gain liabilities. J. Clin. Psychiatry 60:358-363 (1999) DOI |
19 | Mitscher, L. A. et al. Chemoprevention: a review of the potential therapeutic antioxidant properties of green tea and certain of its constituents. Med. Res. Rev. 17:327-365 (1997) DOI ScienceOn |
20 | Melkersson, K. I. & Hulting, A. L. Insulin and leptin levels in patients with schizophrenia or related psychoses- a comparison between different antipsychotic agents. Psychopharmacology 154:205-212 (2001) DOI |
21 | Ryu, J. C., Kim, M. K., Choi, M. H. & Chun, T. H. Promising next generation technology in toxicologytoxicogenomics. Mol. Cell. Toxicol. 1:1-6 (2005) |
22 | Ratzoni, G. et al. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J. Am. Acad. Child Adolesc Psychiatry 41:337-343 (2002) DOI ScienceOn |
23 | Remschmidt, H. et al. Atypical neuroleptics in child and adolescent psychiatry. Eur. Child Adolescent Psychiatry 9:119 (2000) |
24 | Kao, Y. H., Hiipakka, R. A. & Liao, S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141:980-987 (2000b) DOI ScienceOn |
25 | Chantre, P. & Lairon, D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 9:1-6 (2002) |
26 | Newcomer, J. W. et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry 59:337-345 (2002) DOI |
27 | Masand, P. S. & Gupta, S. Long-term adverse effects of novel antipsychotics. J. Psychiatr. Pract. 6:299- 309 (2000) DOI ScienceOn |
28 | Meyer, J. M. Novel antipsychotics and severe hyperlipidemia. J. Clin. Psychopharmacol. 21:369-374 (2001) DOI ScienceOn |